Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06837597Phase 3Not yet recruiting
A Phase 3 trial of Jianzhong Qushi Formula in chronic radiation proctitis (CRP), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Planned start Mar 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06837597.